Molecular Devices Simplifies Imaging for Quantifying Biological Complexity of iPSC-derived Cardiomyocytes and Neurons

Share Article

In this webinar, which LabRoots will host November 1, participants will learn to implement cost-effective automated imaging with remote acquisition and analysis capabilities.

Oksana Sirenko, PhD Research Scientist, Molecular Devices

There is a current focus in biology towards developing more complex and physiologically relevant in vitro assays and cell models, using phenotypic multi-parameter read-outs, and implementing complex methods of analysis. However, scaling and automating these assays can be challenging. Instruments and technologies that capture the complexity of biological responses with the goal of better understanding the mechanism of healthy or disease-state cells contribute in a meaningful way to avoid unwanted toxic responses or to identify new drug candidates.

Attendees of this webinar will gain a better understanding of how to improve workflow process utilizing new software which comes preloaded with 25 different analysis protocols for image analysis and visualization. They will also learn how to run functional and cytotoxicity assays using various cell models including iPSC-derived cardiac and neuronal cells.

Along with an overview of new tools, like the ImageXpress® Nano Automated Imaging System and CellReporterXpress Image Acquisition and Analysis Software, participants will also get a highlight of new analytical tools for collecting and processing multi-parametric read-outs that will enable scientists to take full advantage of the complexity of biological assays.

The team at Molecular Devices has arrange for Dr. Oksana Sirenko, a research scientist with Molecular Devices, to be the speaker for this event.

Sirenko earned her doctorate in biochemistry and currently serves as a research scientist at Molecular Devices working on development of new technologies for imaging and high content analysis. The focus of her current scientific research is on development methods for high throughput in vitro toxicity screening, including 3D models.

November 1, 2017, beginning at 12:00 PM PT, 3:00 PM ET. To read more about this event, learn about the continuing education credits offered, or to register for free, click here.

About Molecular Devices, LLC
Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.

For more information, visit:

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website